# Epigenome-wide analysis in West Africans identifies DNA methylation markers for circulating adiponectin

**Authors:** Muhulo Muhau Mungamba, Johanna Wijburg, Eva L. van der Linden, Felix P. Chilunga, Ayo P. Doumatey, Amy R. Bentley, Charles F. Hayfron-Benjamin, Constance R. Sewani-Rusike, Benedicta N. Nkeh-Chungag, Rexford S. Ahima, Charles Agyemang, Peter Henneman, Adebowale A. Adeyemo, Charles N. Rotimi, Karlijn A.C. Meeks

PMC · DOI: 10.1016/j.ebiom.2026.106192 · eBioMedicine · 2026-03-06

## TL;DR

This study finds DNA methylation markers linked to adiponectin levels in West African populations, offering insights into how this protein is regulated and its role in metabolic health.

## Contribution

The study identifies novel DNA methylation loci associated with adiponectin in sub-Saharan African populations, a group underrepresented in epigenetic research.

## Key findings

- Three epigenome-wide significant DMPs were identified, located near genes involved in lipid metabolism, proteasomal degradation, and stress responses.
- These DMPs were linked to gene expression changes in blood and adipose tissue, suggesting functional roles in adiponectin regulation.
- The findings highlight potential pathways for further investigation into adiponectin's role in cardiometabolic health.

## Abstract

Adiponectin is a circulating adipokine involved in energy metabolism and inflammation, with reported protective effects against cardiometabolic diseases such as type 2 diabetes (T2D) and early kidney disease. However, its regulation remains poorly understood. This study aimed to identify epigenetic loci associated with adiponectin levels.

DNA methylation was profiled using Illumina 450K and EPIC (850K) arrays in 315 Ghanaians (RODAM-Pros study) and 593 Nigerians (AADM study). Differentially methylated positions (DMPs) were identified using linear regression models adjusted for age, sex, BMI, blood cell proportions, and technical covariates. Analyses were stratified by T2D status and cohort, then meta-analysed to identify DMPs associated with adiponectin across T2D status (combining participants with-and-without diabetes). RNA-seq data on 77 blood, 49 subcutaneous adipose tissue (SAT), and 55 skeletal muscle samples from the AADM study were used to identify eQTMs for identified DMPs.

We identified three epigenome-wide significant DMPs: cg03546163 (Z-score = 5.76, p ≤ 0.001, 5′UTR of FKBP5), cg02561343 (Z-score = 5.11, p ≤ 0.001, within UST), and cg23969380 (Z-score = 5.13, p ≤ 0.001, ADGRD1 body). cg03546163 was an eQTM for PLA2G12B in SAT (beta = −0.039, FDR = 0.047), cg02561343 for PSMD8 (beta = −11.85, FDR = 0.029) and TECR (beta = −9.48, FDR = 0.029) in SAT, and cg23969380 for HIGD2AP1 (beta = −0.095, FDR = 0.024) in blood. These genes have been reported to be involved in lipid metabolism (PLA2G12B and TECR), proteasomal degradation (PSMD8), and cellular stress-responses (HIGD2AP1).

This epigenome-wide study of adiponectin in sub-Saharan African populations identified DNA methylation loci potentially involved in adiponectin regulation through lipid-metabolism, inflammation, proteostasis, and stress–response pathways. These findings provide a foundation for replication and further investigation to improve understanding of the role of adiponectin in cardiometabolic-health.

10.13039/100000002National Institutes of Health and 10.13039/501100000781European Research Council.

## Linked entities

- **Genes:** FKBP5 (FKBP prolyl isomerase 5) [NCBI Gene 2289], UST (uronyl 2-sulfotransferase) [NCBI Gene 10090], ADGRD1 (adhesion G protein-coupled receptor D1) [NCBI Gene 283383], PLA2G12B (phospholipase A2 group XIIB) [NCBI Gene 84647], PSMD8 (proteasome 26S subunit, non-ATPase 8) [NCBI Gene 5714], TECR (trans-2,3-enoyl-CoA reductase) [NCBI Gene 9524], HIGD2AP1 (HIGD2A pseudogene 1) [NCBI Gene 100289360]
- **Diseases:** type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, TECR (trans-2,3-enoyl-CoA reductase) [NCBI Gene 9524] {aka GPSN2, MRT14, SC2, TER}, PLA2G12B (phospholipase A2 group XIIB) [NCBI Gene 84647] {aka FKSG71, GXIIB, GXIIIsPLA2, PLA2G13, sPLA2-GXIIB}, FKBP5 (FKBP prolyl isomerase 5) [NCBI Gene 2289] {aka AIG6, FKBP51, FKBP54, P54, PPIase, Ptg-10}, PSMD8 (proteasome 26S subunit, non-ATPase 8) [NCBI Gene 5714] {aka HEL-S-91n, HIP6, HYPF, Nin1p, Rpn12, S14}, ADGRD1 (adhesion G protein-coupled receptor D1) [NCBI Gene 283383] {aka GPR133, PGR25}
- **Diseases:** cardiometabolic diseases (MESH:D024821), inflammation (MESH:D007249), diabetes (MESH:D003920), kidney disease (MESH:D007674), T2D (MESH:D003924)
- **Chemicals:** lipid (MESH:D008055)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12993010/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12993010/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC12993010/full.md

---
Source: https://tomesphere.com/paper/PMC12993010